The c-MET-JAK1/2-STAT3 signalling axis is a critical mediator of resistance to MEK inhibition in KRAS mutant colorectal cancer

Activity: Talk or presentation typesOral presentation

PeriodFeb 2013
Held atIrish Association of Cancer Research, United Kingdom